Literature DB >> 20190071

Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies.

Timothy J Lott1, João P Frade, Shawn R Lockhart.   

Abstract

The human commensal yeast Candida glabrata is becoming increasingly important as an agent of nosocomial bloodstream infection. However, relatively little is known concerning the genetics and population structure of this species. We have analyzed 230 incident bloodstream isolates from previous and current population-based surveillance studies by using multilocus sequence typing (MLST). Our results show that in the U.S. cities of Atlanta, GA; Baltimore, MD; and San Francisco, CA during three time periods spanning 1992 to 2009, five populations of C. glabrata bloodstream isolates are defined by a relatively small number of sequence types. There is little genetic differentiation in the different C. glabrata populations. We also show that there has been a significant temporal shift in the prevalence of one major subtype in Atlanta. Our results support the concept that both recombination and clonality play a role in the population structure of this species.

Entities:  

Mesh:

Year:  2010        PMID: 20190071      PMCID: PMC2863408          DOI: 10.1128/EC.00002-10

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  18 in total

1.  HyPhy: hypothesis testing using phylogenies.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost; Spencer V Muse
Journal:  Bioinformatics       Date:  2004-10-27       Impact factor: 6.937

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

Authors:  Koichiro Tamura; Joel Dudley; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2007-05-07       Impact factor: 16.240

4.  The epidemiology of candidemia in two United States cities: results of a population-based active surveillance.

Authors:  A S Kao; M E Brandt; W R Pruitt; L A Conn; B A Perkins; D S Stephens; W S Baughman; A L Reingold; G A Rothrock; M A Pfaller; R W Pinner; R A Hajjeh
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

5.  Evidence for recombination in Candida glabrata.

Authors:  Andrew R Dodgson; Claude Pujol; Michael A Pfaller; David W Denning; David R Soll
Journal:  Fungal Genet Biol       Date:  2005-01-22       Impact factor: 3.495

6.  Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.

Authors:  Rana A Hajjeh; Andre N Sofair; Lee H Harrison; G Marshall Lyon; Beth A Arthington-Skaggs; Sara A Mirza; Maureen Phelan; Juliette Morgan; Wendy Lee-Yang; Meral A Ciblak; Lynette E Benjamin; Laurie Thomson Sanza; Sharon Huie; Siew Fah Yeo; Mary E Brandt; David W Warnock
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing.

Authors:  Chi-Yang Lin; Yee-Chun Chen; Hsiu-Jung Lo; Kuo-Wei Chen; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2007-06-06       Impact factor: 5.948

8.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

Authors:  Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

9.  Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; J F Meis; I M Gould; W Fu; A L Colombo; E Rodriguez-Noriega
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

10.  One year prospective survey of Candida bloodstream infections in Scotland.

Authors:  Frank C Odds; Mary F Hanson; Amanda D Davidson; Mette D Jacobsen; Pauline Wright; Julie A Whyte; Neil A R Gow; Brian L Jones
Journal:  J Med Microbiol       Date:  2007-08       Impact factor: 2.472

View more
  22 in total

1.  Breakthrough invasive candidiasis in patients on micafungin.

Authors:  Christopher D Pfeiffer; Guillermo Garcia-Effron; Aimee K Zaas; John R Perfect; David S Perlin; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

2.  Clinical and microbiological investigation of fungemia from four hospitals in China.

Authors:  Danfeng Dong; Zhen Li; Lihua Zhang; Cen Jiang; Enqiang Mao; Xuefeng Wang; Yibing Peng
Journal:  Mycopathologia       Date:  2015-02-27       Impact factor: 2.574

Review 3.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study.

Authors:  R H Jensen; H K Johansen; L M Søes; L E Lemming; F S Rosenvinge; L Nielsen; B Olesen; L Kristensen; E Dzajic; K M T Astvad; M C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

5.  Time-kill assay and Etest evaluation for synergy with polymyxin B and fluconazole against Candida glabrata.

Authors:  George Pankey; Deborah Ashcraft; Heather Kahn; Abdulrahim Ismail
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

6.  Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.

Authors:  Hazim O Khalifa; Teppei Arai; Hidetaka Majima; Akira Watanabe; Katsuhiko Kamei
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

7.  FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.

Authors:  Alicia J Zimbeck; Naureen Iqbal; Angela M Ahlquist; Monica M Farley; Lee H Harrison; Tom Chiller; Shawn R Lockhart
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

8.  Multilocus microsatellite markers for molecular typing of Candida glabrata: application to analysis of genetic relationships between bloodstream and digestive system isolates.

Authors:  A Enache-Angoulvant; M Bourget; S Brisse; C Stockman-Pannier; L Diancourt; N François; D Rimek; C Fairhead; Daniel Poulain; C Hennequin
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

9.  Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multicenter Study in China.

Authors:  Xin Hou; Meng Xiao; He Wang; Shu-Ying Yu; Ge Zhang; Yanan Zhao; Ying-Chun Xu
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

10.  Evaluation of Polymorphic Locus Sequence Typing for Candida glabrata Epidemiology.

Authors:  Santosh Katiyar; Eric Shiffrin; Celeste Shelton; Kelley Healey; John-Paul Vermitsky; Tom Edlind
Journal:  J Clin Microbiol       Date:  2016-02-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.